STERIS plc (STE)
After hours:
| Previous close | 224.29 |
| Open | 220.96 |
| Bid | 221.03 x 800 |
| Ask | 221.38 x 800 |
| Day's range | 217.14 - 223.30 |
| 52-week range | 170.36 - 248.30 |
| Volume | |
| Avg. volume | 450,277 |
| Market cap | 22.116B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 80.40 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.72 (0.78%) |
| Ex-dividend date | 22 Nov 2021 |
| 1y target est | N/A |
- GlobeNewswire
STERIS to Host a Conference Call for Fiscal 2022 Third Quarter Financial Results on February 9, 2022
DUBLIN, IRELAND, Jan. 25, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2022 third quarter financial results at 10:00 a.m. ET on February 9, 2022. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter
- Business Wire
Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS
PITTSBURGH, January 03, 2022--Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS
- GlobeNewswire
STERIS Announces Financial Results for Fiscal 2022 Second Quarter
Second quarter revenue increases 58% as reported; 12% constant currency organicAs reported EPS of $0.69; adjusted EPS of $1.99Company reiterates fiscal 2022 outlook DUBLIN, IRELAND , Nov. 02, 2021 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 second quarter ended September 30, 2021. Revenue as reported for the quarter increased 58% to $1,197 million compared with $756 million in the second quarter of fiscal 2021. Cons
